Highlights Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Delayed Nasdaq Other stock markets 09:52:38 2024-06-12 am EDT			5-day change	1st Jan Change
8.455 ^USD	+1.99%		-3.04%	+213.15%

May. 15	Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 11	Sector Update: Health Care Stocks Softer Late Afternoon	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Sector Update: Health Care Stocks Softer Late Afternoon	Apr. 11	MT
Top Midday Gainers	Apr. 11	MT
Sector Update: Health Care Stocks Decline Thursday Afternoon	Apr. 11	MT
Eliem Therapeutics to Acquire Tenet Medicines; Launching Private Placement -- Eliem Shares Surge	Apr. 11	MT
Top Premarket Gainers	Apr. 11	MT
Eliem Therapeutics, Inc. entered into a definitive acquisition agreement to acquire Tenet Medicines, Inc.	Apr. 10	CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Eliem Therapeutics Plans to Explore Strategic Alternatives	23-07-20	CI
Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
ELIEM THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-06	AQ
Eliem Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-06	CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-06	CI
North American Morning Briefing : Stock Futures -3-	23-02-13	DJ
ELIEM THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Results and Operations (form 10-Q)	22-11-14	AQ
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Eliem Therapeutics, Inc. Provides Update on Pipeline Progress	22-10-05	CI
ELIEM THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Results and Operations (form 10-Q)	22-08-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Highlights

Filters